Abstract

Computer-aided research on the relationship between molecular structures of natural compounds (NC) and their biological activities have been carried out extensively because the molecular structures of new drug candidates are usually analogous to or derived from the molecular structures of NC. In order to express the relationship physically realistically using a computer, it is essential to have a molecular descriptor set that can adequately represent the characteristics of the molecular structures belonging to the NC’s chemical space. Although several topological descriptors have been developed to describe the physical, chemical, and biological properties of organic molecules, especially synthetic compounds, and have been widely used for drug discovery researches, these descriptors have limitations in expressing NC-specific molecular structures. To overcome this, we developed a novel molecular fingerprint, called Natural Compound Molecular Fingerprints (NC-MFP), for explaining NC structures related to biological activities and for applying the same for the natural product (NP)-based drug development. NC-MFP was developed to reflect the structural characteristics of NCs and the commonly used NP classification system. NC-MFP is a scaffold-based molecular fingerprint method comprising scaffolds, scaffold-fragment connection points (SFCP), and fragments. The scaffolds of the NC-MFP have a hierarchical structure. In this study, we introduce 16 structural classes of NPs in the Dictionary of Natural Product database (DNP), and the hierarchical scaffolds of each class were calculated using the Bemis and Murko (BM) method. The scaffold library in NC-MFP comprises 676 scaffolds. To compare how well the NC-MFP represents the structural features of NCs compared to the molecular fingerprints that have been widely used for organic molecular representation, two kinds of binary classification tasks were performed. Task I is a binary classification of the NCs in commercially available library DB into a NC or synthetic compound. Task II is classifying whether NCs with inhibitory activity in seven biological target proteins are active or inactive. Two tasks were developed with some molecular fingerprints, including NC-MFP, using the 1-nearest neighbor (1-NN) method. The performance of task I showed that NC-MFP is a practical molecular fingerprint to classify NC structures from the data set compared with other molecular fingerprints. Performance of task II with NC-MFP outperformed compared with other molecular fingerprints, suggesting that the NC-MFP is useful to explain NC structures related to biological activities. In conclusion, NC-MFP is a robust molecular fingerprint in classifying NC structures and explaining the biological activities of NC structures. Therefore, we suggest NC-MFP as a potent molecular descriptor of the virtual screening of NC for natural product-based drug development.

Highlights

  • Natural compounds (NC), which are chemical compounds produced by living organisms, have been a significant source of traditional medicine [1]

  • Generation of NC‐MFP scaffold library As described by Eq 1, the Natural Compound Molecular Fingerprints (NC-MFP) scaffold library consists of libraries with 16 classes, and each class consists of a scaffold library of level 0, level 1, level 2, and level 3, respectively, with the Dictionary of Natural Products (DNP) consisting of representative compounds for each class

  • The scaffold of NC-MFP was generated from representative compounds of each class in DNP using the Bemis and Murko (BM) method

Read more

Summary

Introduction

Natural compounds (NC), which are chemical compounds produced by living organisms, have been a significant source of traditional medicine [1]. Since the known NCs have a wide range of biological activities with structural diversity compared to synthetic compounds, they have been recognized as a valuable resource for pharmaceuticals [3,4,5]. Since many metabolic pathways are shared among various life forms, life forms may share metabolites with the same or similar molecular structure. NC structures are usually analogous to metabolite [6]. For this reason, NCs are capable of exhibiting various types of physiological activities and become an essential source of precursors for new drug development [7]. According to the US Food and Drug Administration (FDA), NCs accounted for 6%, derivatives of NCs accounted for 26%, and mimetics of NCs accounts for 32% of the approved small molecule drugs between 1981 and 2014 [8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call